<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NNR</journal-id>
<journal-id journal-id-type="hwp">spnnr</journal-id>
<journal-id journal-id-type="nlm-ta">Neurorehabil Neural Repair</journal-id>
<journal-title>Neurorehabilitation and Neural Repair</journal-title>
<issn pub-type="ppub">1545-9683</issn>
<issn pub-type="epub">1552-6844</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1545968312461719</article-id>
<article-id pub-id-type="publisher-id">10.1177_1545968312461719</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Recovery Following Stroke</article-title>
<subtitle>Capturing Changes in Upper-Extremity Function</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Simpson</surname><given-names>Lisa A.</given-names></name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff1-1545968312461719">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Eng</surname><given-names>Janice J.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312461719">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1545968312461719"><label>1</label>University of British Columbia, Vancouver, BC, Canada</aff>
<author-notes>
<corresp id="corresp1-1545968312461719">Janice J. Eng, PhD, Department of Physical Therapy, University of British Columbia, 212-2177 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada Email: <email>janice.eng@ubc.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>240</fpage>
<lpage>250</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Society of Neurorehabilitation</copyright-holder>
</permissions>
<abstract>
<p><italic>Background and purpose</italic>. Augmenting changes in recovery is core to the rehabilitation process following a stroke. Hence it is essential that outcome measures are able to detect change as it occurs, a property known as responsiveness. This article critically reviewed the responsiveness of functional outcome measures following stroke, specifically examining tools that captured upper-extremity (UE) functional recovery. <italic>Methods</italic>. A systematic search of the literature was undertaken to identify articles providing responsiveness data for 3 types of change (observed, detectable, and important). <italic>Results</italic>. Data from 68 articles for 14 UE functional outcome measures were retrieved. Larger percentage changes were required to be considered important when obtained through anchor-based methods (eg, based on patient opinion or comparative measure) compared with distribution methods (eg, statistical estimates). Larger percentage changes were required to surpass the measurement error for patient-perceived functional measures (eg, Motor Activity Log) compared with laboratory-based performance measures (eg, Action Research Arm Test). The majority of rehabilitation interventions have similar effect sizes on patient-perceived UE function and laboratory-based UE function. <italic>Conclusions</italic>. The magnitude of important change or change that surpasses measurement error can vary substantially depending on the method of calculation. Rehabilitation treatments can affect patient perceptions of functional change as effectively as laboratory-based functional measures; however, larger sample sizes may be required to account for the larger measurement error associated with patient-perceived functional measures.</p>
</abstract>
<kwd-group>
<kwd>stroke</kwd>
<kwd>systematic review</kwd>
<kwd>recovery of function</kwd>
<kwd>responsiveness</kwd>
<kwd>treatment outcome</kwd>
<kwd>rehabilitation</kwd>
<kwd>UE</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March/April 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1545968312461719" sec-type="intro">
<title>Introduction</title>
<p>Functional recovery following stroke is complex, with wide variation in natural recovery and response to treatment across individuals. Optimizing or augmenting changes in recovery is core to the rehabilitation process following a stroke. Hence it is essential that outcome measures are able to detect change as it occurs, a property known as responsiveness.<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref>,<xref ref-type="bibr" rid="bibr2-1545968312461719">2</xref></sup></p>
<p>Detecting change over time or from an intervention is one of the most critical requisites of an outcome measure; it is necessary information for selecting the best instrument for practice or research and for determining sample size for clinical studies. Furthermore, there is growing recognition that traditional reporting of statistical significance tests and effects sizes should be accompanied by methods for determining meaningful or important change.<sup><xref ref-type="bibr" rid="bibr3-1545968312461719">3</xref></sup></p>
<p>Beaton et al<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref></sup> argue that responsiveness is a context-specific characteristic that is influenced by factors such as the specific sample, treatment, and the type of change captured by an instrument. The authors outline 3 major types of change in their responsiveness taxonomy. They are as follows: (1) observed change, (2) important change, and (3) detectable change. <xref ref-type="fig" rid="fig1-1545968312461719">Figure 1</xref> depicts the interrelationship between the 3 types of change and the common metrics used to quantify them. Observed change is the amount of change observed in a population in which change is expected to occur (ie, after a treatment of known efficacy or a specific period within the natural recovery pattern). Traditional methods have captured this type of change with an effect size.<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref></sup> Important change is the observed change estimated to be meaningful and is often quantified as a minimally clinically important difference (MCID) value. For example, important change may reflect the value that patients, clinicians, or society places on the recovery (or partial recovery) of a task, such as the ability to bring a spoon to the mouth. Finally, detectable change takes into consideration the measurement error associated with a tool and is often quantified as a minimal detectable change score (MDC) or limit of agreement. Calculation of the MDC value associated with a measure varies depending on the confidence level selected. The most common confidence levels selected are 95% and 90% and are denoted by the subscripts MDC<sub>95</sub> and MDC<sub>90</sub>. Confidence that true functional change has been observed in a clinical study is increased when the observed change is equal to or surpasses a measure’s detectable change values.<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref></sup></p>
<fig id="fig1-1545968312461719" position="float">
<label>Figure 1.</label>
<caption>
<p>Graphic representation of observed, detectable, and important change. Abbreviations: MDC<sub>90</sub>, minimal detectable change (with 90% confidence interval); MDC<sub>95</sub>, minimal detectable change (with 95% confidence interval); LOA, limits of agreement; PES, population effect size; SRM, standardized response mean; MCID, minimally clinically important difference.</p>
</caption>
<graphic xlink:href="10.1177_1545968312461719-fig1.tif"/></fig>
<p>The purpose of this article is to synthesize and critically review the research evidence that captures responsiveness as defined by 3 types of change (observed, important, and detectable). This systematic review provides an understanding of the responsiveness of outcome measures used in stroke research, specifically within the context of upper-extremity (UE) functional recovery.</p>
</sec>
<sec id="section2-1545968312461719" sec-type="methods">
<title>Methods</title>
<sec id="section3-1545968312461719">
<title>Literature Search</title>
<p>This review targeted articles that capture 3 types of change (observed, important, and detectable) using UE functional outcome measures following a stroke. Articles were identified using a systematic search of electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Central) from database inception through March 2012. The following keywords were used: stroke, cerebrovascular accident or hemiplegia or hemiparesis combined with upper extremity, function or activities of daily living and responsiveness, reliability, psychometrics, “minimally clinically important change or MCID,” “standard error of measurement or SEM,” “minimal detectable change or MDC,” “standardized response mean or SRM,” and effect size or outcome measurement. All terms were mapped onto subject headings. Articles were limited to the English language, human subjects, and adults. A hand search of reference lists from reviews and the gray literature (eg, StrokEngine Assess) was also conducted to ensure a thorough search.<sup><xref ref-type="bibr" rid="bibr4-1545968312461719">4</xref></sup></p>
</sec>
<sec id="section4-1545968312461719">
<title>Inclusion Criteria</title>
<p>To be included in this review, articles had to meet the following inclusion criteria: they had to (1) provide a responsiveness index or sufficient information to calculate responsiveness index (eg, MDC or effect size); (2) use a sample of individuals with stroke; (3) use an outcome measure that assessed affected UE ability and included ≥50% functional activities (to ensure scale reflected International Classification of Functioning, Disability, and Health activity domain); and (4) be published in a peer-reviewed journal. Articles were excluded if they were (1) conference proceedings or abstracts; (2) pre-post studies or randomized control trials (RCTs), which calculated a responsiveness index without using the control group information to minimize bias for inflation of the effect sizes<sup><xref ref-type="bibr" rid="bibr5-1545968312461719">5</xref></sup>; (3) studies with a sample size less than 10; and (4) studies that used measures that captured UE function as a single action (eg, box and blocks test, peg test). Single actions were not considered representative of the many actions involved in UE function. RCTs were excluded if they (1) used &lt;2 UE functional outcome measures or (2) found no significant effects for UE function.</p>
</sec>
<sec id="section5-1545968312461719">
<title>Data Extraction and Organization</title>
<p>Responsiveness indices were extracted or calculated from the included articles and subsequently organized into the 3 categories of change outlined by Beaton et al<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref></sup>: (1) observed change, (2) important change, and (3) detectable change (<xref ref-type="fig" rid="fig1-1545968312461719">Figure 1</xref>). Observed change was further subdivided into (1) change over natural recovery (categorized into &lt;3 months postinjury and ≥3 months postinjury) and (2) change in response to an effective treatment. Effect sizes were calculated based on the change score divided by the baseline standard deviation, and MDC values (MDC<sub>90</sub>, MDC<sub>95</sub>) were calculated based on the test-retest coefficient (intraclass correlation coefficient) and the baseline standard deviation.<sup><xref ref-type="bibr" rid="bibr6-1545968312461719">6</xref></sup> In addition, MDC<sub>95</sub>%, which are independent of measurement units, were calculated to compare MDC values across measures.<sup><xref ref-type="bibr" rid="bibr7-1545968312461719">7</xref></sup> We present the MDC<sub>95</sub>% using the 2 methods commonly cited in the rehabilitation literature: (1) MDC<sub>95</sub>/maximum score for the scale (eg, 57 points for Action Research Arm Test [ARAT]) and (2) MDC<sub>95</sub>/baseline mean of the sample.</p>
<p>RCTs that used at least 2 different functional outcome measures were used to estimate observed change in response to a treatment of known efficacy. This allowed for comparison of observed change across different measures within the same study by controlling for variation in treatment and sample characteristics.<sup><xref ref-type="bibr" rid="bibr8-1545968312461719">8</xref></sup> To ensure that we were capturing observed change in response to an effective treatment, only RCTs that found a significant effect for at least one of the UE functional measures were included. Scatter plots of effect sizes were generated for a visual representation of one outcome measures’ relative ability to capture change compared with another measure in response to the same treatment with the same sample. When only median and range scores were provided, mean and standard deviation values were estimated using the method suggested by Hozo et al<sup><xref ref-type="bibr" rid="bibr9-1545968312461719">9</xref></sup> to calculate an effect size.</p>
</sec></sec>
<sec id="section6-1545968312461719" sec-type="results">
<title>Results</title>
<p>The search strategy yielded 1770 titles of which 68 met the inclusion criteria (<xref ref-type="fig" rid="fig2-1545968312461719">Figure 2</xref>). The articles provided responsiveness data for 14 functional outcome measures.<sup><xref ref-type="bibr" rid="bibr10-1545968312461719">10</xref><xref ref-type="bibr" rid="bibr11-1545968312461719"/><xref ref-type="bibr" rid="bibr12-1545968312461719"/><xref ref-type="bibr" rid="bibr13-1545968312461719"/><xref ref-type="bibr" rid="bibr14-1545968312461719"/><xref ref-type="bibr" rid="bibr15-1545968312461719"/><xref ref-type="bibr" rid="bibr16-1545968312461719"/><xref ref-type="bibr" rid="bibr17-1545968312461719"/><xref ref-type="bibr" rid="bibr18-1545968312461719"/><xref ref-type="bibr" rid="bibr19-1545968312461719"/><xref ref-type="bibr" rid="bibr20-1545968312461719"/><xref ref-type="bibr" rid="bibr21-1545968312461719"/><xref ref-type="bibr" rid="bibr22-1545968312461719"/><xref ref-type="bibr" rid="bibr23-1545968312461719"/><xref ref-type="bibr" rid="bibr24-1545968312461719"/><xref ref-type="bibr" rid="bibr25-1545968312461719"/><xref ref-type="bibr" rid="bibr26-1545968312461719"/><xref ref-type="bibr" rid="bibr27-1545968312461719"/><xref ref-type="bibr" rid="bibr28-1545968312461719"/><xref ref-type="bibr" rid="bibr29-1545968312461719"/><xref ref-type="bibr" rid="bibr30-1545968312461719"/><xref ref-type="bibr" rid="bibr31-1545968312461719"/><xref ref-type="bibr" rid="bibr32-1545968312461719"/><xref ref-type="bibr" rid="bibr33-1545968312461719"/><xref ref-type="bibr" rid="bibr34-1545968312461719"/><xref ref-type="bibr" rid="bibr35-1545968312461719"/><xref ref-type="bibr" rid="bibr36-1545968312461719"/><xref ref-type="bibr" rid="bibr37-1545968312461719"/><xref ref-type="bibr" rid="bibr38-1545968312461719"/><xref ref-type="bibr" rid="bibr39-1545968312461719"/><xref ref-type="bibr" rid="bibr40-1545968312461719"/><xref ref-type="bibr" rid="bibr41-1545968312461719"/><xref ref-type="bibr" rid="bibr42-1545968312461719"/><xref ref-type="bibr" rid="bibr43-1545968312461719"/><xref ref-type="bibr" rid="bibr44-1545968312461719"/><xref ref-type="bibr" rid="bibr45-1545968312461719"/><xref ref-type="bibr" rid="bibr46-1545968312461719"/><xref ref-type="bibr" rid="bibr47-1545968312461719"/><xref ref-type="bibr" rid="bibr48-1545968312461719"/><xref ref-type="bibr" rid="bibr49-1545968312461719"/><xref ref-type="bibr" rid="bibr50-1545968312461719"/><xref ref-type="bibr" rid="bibr51-1545968312461719"/><xref ref-type="bibr" rid="bibr52-1545968312461719"/><xref ref-type="bibr" rid="bibr53-1545968312461719"/><xref ref-type="bibr" rid="bibr54-1545968312461719"/><xref ref-type="bibr" rid="bibr55-1545968312461719"/><xref ref-type="bibr" rid="bibr56-1545968312461719"/><xref ref-type="bibr" rid="bibr57-1545968312461719"/><xref ref-type="bibr" rid="bibr58-1545968312461719"/><xref ref-type="bibr" rid="bibr59-1545968312461719"/><xref ref-type="bibr" rid="bibr60-1545968312461719"/><xref ref-type="bibr" rid="bibr61-1545968312461719"/><xref ref-type="bibr" rid="bibr62-1545968312461719"/><xref ref-type="bibr" rid="bibr63-1545968312461719"/><xref ref-type="bibr" rid="bibr64-1545968312461719"/><xref ref-type="bibr" rid="bibr65-1545968312461719"/><xref ref-type="bibr" rid="bibr66-1545968312461719"/><xref ref-type="bibr" rid="bibr67-1545968312461719"/><xref ref-type="bibr" rid="bibr68-1545968312461719"/><xref ref-type="bibr" rid="bibr69-1545968312461719"/><xref ref-type="bibr" rid="bibr70-1545968312461719"/><xref ref-type="bibr" rid="bibr71-1545968312461719"/><xref ref-type="bibr" rid="bibr72-1545968312461719"/><xref ref-type="bibr" rid="bibr73-1545968312461719"/><xref ref-type="bibr" rid="bibr74-1545968312461719"/><xref ref-type="bibr" rid="bibr75-1545968312461719"/><xref ref-type="bibr" rid="bibr76-1545968312461719"/>-<xref ref-type="bibr" rid="bibr77-1545968312461719">77</xref></sup> <xref ref-type="table" rid="table1-1545968312461719">Table 1</xref> displays the number of articles that provided responsiveness estimates for each measure. The ARAT, Motor Activity Log (MAL), Wolf Motor Function test (Wolf), and Stroke Impact Scale (SIS) were the 4 most frequently used measures among the included articles.</p>
<fig id="fig2-1545968312461719" position="float">
<label>Figure 2.</label>
<caption>
<p>Flow diagram of process to select final list of included articles and outcome measures. Abbreviations: OM, outcome measure; AMAT, Arm Motor Activity Test; ARAT, Action Research Arm Test; CAHAI, Chedoke Arm and Hand Activity Inventory; Duruoz, Duruoz Hand Index; Frenchay, Frenchay Arm Test; FTHUE, Functional Test for the Hemiplegic Upper Extremity; Jebsen, Jebsen Hand Function Test; MAL, Motor Activity Log; SIS, Stroke Impact Scale; TEMPA, Upper Extremity Performance Scale for the Elderly; Wolf, Wolf Motor Function Test.</p>
</caption>
<graphic xlink:href="10.1177_1545968312461719-fig2.tif"/></fig>
<table-wrap id="table1-1545968312461719" position="float">
<label>Table 1.</label>
<caption>
<p>MCID Values Calculated by Distribution and Anchor-Based Methods<sup><xref ref-type="table-fn" rid="table-fn2-1545968312461719">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table1-1545968312461719" xlink:href="10.1177_1545968312461719-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">ABILHAND</th>
<th align="center">Acceler</th>
<th align="center">ARAT</th>
<th align="center">MAL QOM</th>
<th align="center">MAL AOU</th>
<th align="center">SIS</th>
<th align="center">Wolf FAS</th>
<th align="center">Wolf Time</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="9">MCID obtained by distribution-based methods<sup><xref ref-type="table-fn" rid="table-fn3-1545968312461719">b</xref></sup></td>
</tr>
<tr>
<td> Effect size</td>
<td>0.26<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref></sup> (in logits)</td>
<td/>
<td/>
<td/>
<td/>
<td>5.8<sup><xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup> (5.8%)</td>
<td>0.14<sup><xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> (2.8%)</td>
<td>1.4<sup><xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> (1.1%)</td>
</tr>
<tr>
<td colspan="9">MCID obtained by anchor-based methods<sup><xref ref-type="table-fn" rid="table-fn4-1545968312461719">c</xref></sup></td>
</tr>
<tr>
<td> Fugl-Meyer</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>0.33<sup><xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> (6.6%)</td>
<td>1.64<sup><xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> (1.4%)</td>
</tr>
<tr>
<td> Percentage recovery</td>
<td>0.35<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref></sup> (In logits)</td>
<td/>
<td/>
<td/>
<td>NS<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref></sup></td>
<td>17.8<sup><xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup> (17.8%)</td>
<td/>
<td>NS<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref></sup></td>
</tr>
<tr>
<td> Global</td>
<td/>
<td>NS<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup></td>
<td>12-17<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> (21%-30%)</td>
<td>1.0-1.1<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> (20%-22%)</td>
<td/>
<td/>
<td>1.0-1.2<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> (20%-24%)</td>
<td>19.0<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> (16%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1545968312461719"><p>Abbreviations: MCID, minimally clinically important difference; Acceler, Accelerometry; ARAT, Action Research Arm Test; MAL, Motor Activity Log; QOM, Quality of Movement Scale; AOU, Amount of Use Scale; SIS, Stroke Impact Scale; Wolf, Wolf Motor Function Test; FAS, Functional Ability Scale; NS, MCID values could not be calculated because there was a relationship between change scores and global recovery scales; logits, log odds scale units that allow Likert scale scores (ie, ABILHAND raw scores) to be interpreted as interval scores.<sup><xref ref-type="bibr" rid="bibr78-1545968312461719">78</xref></sup></p></fn>
<fn id="table-fn2-1545968312461719">
<label>a</label>
<p>MCID values are displayed in raw scores (percentage of scale maximum score).</p></fn>
<fn id="table-fn3-1545968312461719">
<label>b</label>
<p>An effect size of 0.2 was used as the distribution method to determine MCID.</p></fn>
<fn id="table-fn4-1545968312461719">
<label>c</label>
<p>Anchor-based methods used to calculate MCID consisted of: Fugl-Meyer, change of 6 to 10 points on the Fugl-Meyer upper-extremity scale; percentage recovery, 10% to 15% or 50% recovery on the SIS global recovery item; global, perception of important change on a global rating scale.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="section7-1545968312461719">
<title>Observed Change</title>
<sec id="section8-1545968312461719">
<title>Observed change over natural recovery</title>
<p>Effect sizes that captured change over time of participants in standard care were extracted or calculated from 25 studies.<sup><xref ref-type="bibr" rid="bibr10-1545968312461719">10</xref><xref ref-type="bibr" rid="bibr11-1545968312461719"/><xref ref-type="bibr" rid="bibr12-1545968312461719"/><xref ref-type="bibr" rid="bibr13-1545968312461719"/><xref ref-type="bibr" rid="bibr14-1545968312461719"/><xref ref-type="bibr" rid="bibr15-1545968312461719"/><xref ref-type="bibr" rid="bibr16-1545968312461719"/><xref ref-type="bibr" rid="bibr17-1545968312461719"/><xref ref-type="bibr" rid="bibr18-1545968312461719"/><xref ref-type="bibr" rid="bibr19-1545968312461719"/><xref ref-type="bibr" rid="bibr20-1545968312461719"/><xref ref-type="bibr" rid="bibr21-1545968312461719"/><xref ref-type="bibr" rid="bibr22-1545968312461719"/><xref ref-type="bibr" rid="bibr23-1545968312461719"/><xref ref-type="bibr" rid="bibr24-1545968312461719"/><xref ref-type="bibr" rid="bibr25-1545968312461719"/><xref ref-type="bibr" rid="bibr26-1545968312461719"/><xref ref-type="bibr" rid="bibr27-1545968312461719"/><xref ref-type="bibr" rid="bibr28-1545968312461719"/><xref ref-type="bibr" rid="bibr29-1545968312461719"/><xref ref-type="bibr" rid="bibr30-1545968312461719"/><xref ref-type="bibr" rid="bibr31-1545968312461719"/><xref ref-type="bibr" rid="bibr32-1545968312461719"/><xref ref-type="bibr" rid="bibr33-1545968312461719"/>-<xref ref-type="bibr" rid="bibr34-1545968312461719">34</xref></sup> It was found that 14 studies followed participants up to 3 months poststroke, and 10 studies followed participants up to 6 months poststroke. Because only 1 study followed participants past 6 months poststroke, we compared the effect sizes for participants at less than 3 months with those at greater than or equal to 3 months postinjury. The majority of studies had observation periods from 2 to 5 months.</p>
<p>Effect sizes calculated at a baseline of 1 to 3 months postinjury were larger and showed greater variance than effect sizes calculated at a baseline ≥3 months postinjury (<xref ref-type="fig" rid="fig3-1545968312461719">Figure 3</xref>). This finding was evident when the duration of follow-up was similar between the 2 groups. Two studies<sup><xref ref-type="bibr" rid="bibr17-1545968312461719">17</xref>,<xref ref-type="bibr" rid="bibr25-1545968312461719">25</xref></sup> considered the effect of stroke severity on observed changes over recovery; effect sizes were 2.0 to 2.6 times larger for individuals with less severe impairments at 1 to 2 months poststroke at study baseline. Three studies<sup><xref ref-type="bibr" rid="bibr13-1545968312461719">13</xref>,<xref ref-type="bibr" rid="bibr31-1545968312461719">31</xref>,<xref ref-type="bibr" rid="bibr33-1545968312461719">33</xref></sup> calculated effect sizes using 2 methods: population effect size (based on the change score divided by baseline standard deviation) and standardized response mean (based on the change score divided by the change score standard deviation) for the same measure. In all 3 studies, the effect sizes calculated as a standardized response mean were larger than when calculated as a population effect size (Supplementary Table 2).</p>
<fig id="fig3-1545968312461719" position="float">
<label>Figure 3.</label>
<caption>
<p>Effect sizes by measure calculated at &lt;3 months and ≥3 months poststroke. The full range of the effect sizes for the Frenchay is 0.2 to 5. The bars on the graph represent the range of effect sizes calculated from studies that measured UE function across time.</p>
<p>Abbreviations: Wolf, Wolf Motor Function Test; Duruoz, Duruoz Hand Index; TEMPA, Upper Extremity Performance Scale for the Elderly; FTHUE, Functional Test for the Hemiplegic Upper Extremity; Jebsen, Jebsen Hand Function Test; CAHAI, Chedoke Arm and Hand Inventory; SIS, Stroke Impact Scale (hand scale); ARAT, Action Research Arm Test; Frenchay, Frenchay Arm Test.</p>
</caption>
<graphic xlink:href="10.1177_1545968312461719-fig3.tif"/></fig>
</sec>
<sec id="section9-1545968312461719">
<title>Observed change in response to a treatment of known efficacy</title>
<p>A total of 28 RCTs used more than 1 UE functional outcome measure and obtained a significant effect for at least 1 of these measures. <sup><xref ref-type="bibr" rid="bibr35-1545968312461719">35</xref><xref ref-type="bibr" rid="bibr36-1545968312461719"/><xref ref-type="bibr" rid="bibr37-1545968312461719"/><xref ref-type="bibr" rid="bibr38-1545968312461719"/><xref ref-type="bibr" rid="bibr39-1545968312461719"/><xref ref-type="bibr" rid="bibr40-1545968312461719"/><xref ref-type="bibr" rid="bibr41-1545968312461719"/><xref ref-type="bibr" rid="bibr42-1545968312461719"/><xref ref-type="bibr" rid="bibr43-1545968312461719"/><xref ref-type="bibr" rid="bibr44-1545968312461719"/><xref ref-type="bibr" rid="bibr45-1545968312461719"/><xref ref-type="bibr" rid="bibr46-1545968312461719"/><xref ref-type="bibr" rid="bibr47-1545968312461719"/><xref ref-type="bibr" rid="bibr48-1545968312461719"/><xref ref-type="bibr" rid="bibr49-1545968312461719"/><xref ref-type="bibr" rid="bibr50-1545968312461719"/><xref ref-type="bibr" rid="bibr51-1545968312461719"/><xref ref-type="bibr" rid="bibr52-1545968312461719"/><xref ref-type="bibr" rid="bibr53-1545968312461719"/><xref ref-type="bibr" rid="bibr54-1545968312461719"/><xref ref-type="bibr" rid="bibr55-1545968312461719"/><xref ref-type="bibr" rid="bibr56-1545968312461719"/><xref ref-type="bibr" rid="bibr57-1545968312461719"/><xref ref-type="bibr" rid="bibr58-1545968312461719"/><xref ref-type="bibr" rid="bibr59-1545968312461719"/><xref ref-type="bibr" rid="bibr60-1545968312461719"/><xref ref-type="bibr" rid="bibr61-1545968312461719"/>-<xref ref-type="bibr" rid="bibr62-1545968312461719">62</xref></sup> These 28 RCTs were used to examine observed change of different measures in response to a treatment of known efficacy within the same study. Constraint-induced movement therapy (CIMT) was the most frequently studied intervention among the included RCTs (50%). Also, the majority of these studies (n = 23) used a laboratory-based performance measure (eg, ARAT, Wolf) in addition to a measure that captured perceived function in one’s own environment (eg, MAL, SIS). The most common outcome measures used together were the MAL with the ARAT (used in 7 studies)<sup><xref ref-type="bibr" rid="bibr35-1545968312461719">35</xref><xref ref-type="bibr" rid="bibr36-1545968312461719"/><xref ref-type="bibr" rid="bibr37-1545968312461719"/><xref ref-type="bibr" rid="bibr38-1545968312461719"/><xref ref-type="bibr" rid="bibr39-1545968312461719"/><xref ref-type="bibr" rid="bibr40-1545968312461719"/>-<xref ref-type="bibr" rid="bibr41-1545968312461719">41</xref></sup> or MAL with the Wolf (used in 10 studies).<sup><xref ref-type="bibr" rid="bibr42-1545968312461719">42</xref><xref ref-type="bibr" rid="bibr43-1545968312461719"/><xref ref-type="bibr" rid="bibr44-1545968312461719"/><xref ref-type="bibr" rid="bibr45-1545968312461719"/><xref ref-type="bibr" rid="bibr46-1545968312461719"/><xref ref-type="bibr" rid="bibr47-1545968312461719"/><xref ref-type="bibr" rid="bibr48-1545968312461719"/><xref ref-type="bibr" rid="bibr49-1545968312461719"/><xref ref-type="bibr" rid="bibr50-1545968312461719"/>-<xref ref-type="bibr" rid="bibr51-1545968312461719">51</xref></sup></p>
<p>The majority of effect sizes demonstrated close to a 1:1 relationship between the laboratory-based and patient-perceived functional measures within the same study (<xref ref-type="fig" rid="fig4-1545968312461719">Figure 4</xref>). Effect sizes from studies that investigated CIMT<sup><xref ref-type="bibr" rid="bibr36-1545968312461719">36</xref><xref ref-type="bibr" rid="bibr37-1545968312461719"/>-<xref ref-type="bibr" rid="bibr38-1545968312461719">38</xref>,<xref ref-type="bibr" rid="bibr46-1545968312461719">46</xref>,<xref ref-type="bibr" rid="bibr47-1545968312461719">47</xref></sup> and 1 study that examined the effect of mirror therapy for individuals with Complex Regional Pain Syndrome<sup><xref ref-type="bibr" rid="bibr43-1545968312461719">43</xref></sup> did not demonstrate this 1:1 relationship. Effect sizes for the perceived effect (MAL) were 1.6 to 6.2 times larger than the functional changes (measured by ARAT or Wolf) in these studies.</p>
<fig id="fig4-1545968312461719" position="float">
<label>Figure 4.</label>
<caption>
<p>Comparison of observed change captured by lab-based versus patient-perceived functional measures. Points on the graph represent the effect sizes obtained from a single study. Lines on the graph represent a 1:1 relationship between the laboratory-based and patient-perceived functional measures. Laboratory-based measures are located on the x axes (ie, Wolf, ARAT). Patient-perceived functional measures are located on the y axes (ie, MAL).</p>
<p>Abbreviations: MAL, Motor Activity Log; AOU, Amount of Use Scale; QOM, Quality of Movement Scale; ARAT, Action Research Arm Test; Wolf, Wolf Motor Function Test; FAS, Functional Ability Scale.</p>
</caption>
<graphic xlink:href="10.1177_1545968312461719-fig4.tif"/></fig>
</sec>
</sec>
<sec id="section10-1545968312461719">
<title>Important Change</title>
<p>Five studies established important change (MCID) values for 6 functional outcome measures (see <xref ref-type="table" rid="table1-1545968312461719">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref><xref ref-type="bibr" rid="bibr64-1545968312461719"/><xref ref-type="bibr" rid="bibr65-1545968312461719"/><xref ref-type="bibr" rid="bibr66-1545968312461719"/>-<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> All but 1 study calculated MCID values from CIMT trials.<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref>,<xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref>,<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> The other study investigated change following robotic therapy.<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref></sup> Four studies<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref><xref ref-type="bibr" rid="bibr66-1545968312461719"/>-<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> used individuals with chronic stroke, and 1 study sample consisted of individuals with acute stroke.<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup></p>
<p>Three studies<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref><xref ref-type="bibr" rid="bibr66-1545968312461719"/>-<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> used a combination of anchor and distribution-based techniques, whereas 2 studies<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> used only anchor-based methods to define important change. Anchor-based methods compare the change scores on the measure of interest with a comparative measure or anchor of important change.<sup><xref ref-type="bibr" rid="bibr79-1545968312461719">79</xref></sup> The following anchors were used in the 5 studies: (1) a predetermined level on a global rating scale in which participants were asked to rate their perception of functional change<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup>; (2) a predetermined level of recovery on the SIS global recovery item<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref>,<xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup>; and (3) a change score of 6 to 10 points on the UE portion of the Fugl-Meyer assessment.<sup><xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> Distribution-based methods determine important change based on the statistical distribution of the results.<sup><xref ref-type="bibr" rid="bibr79-1545968312461719">79</xref></sup> Three studies used 0.2 times the standard deviation of the sample (ie, effect size of 0.2) to determine MCID values.<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref><xref ref-type="bibr" rid="bibr66-1545968312461719"/>-<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup></p>
<p>Important change values displayed large variation, with values spanning from 1.1% to 30% of the tests’ maximum scores. The largest values were observed in the study that used a sample of individuals in the acute stage poststroke.<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> In addition, MCID values calculated using statistically derived distribution-based methods were substantially smaller (15%-88% less) than the values determined by anchor-based methods (<xref ref-type="table" rid="table1-1545968312461719">Table 1</xref>). For example, the MCID for the SIS-hand ranged from a value of 5.8 using an effect size method (distribution method) to 17.8 using perceived amount of recovery on the global recovery question (participant-perceived anchor-based method) for the same sample of individuals.<sup><xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup></p>
<p>Three studies were not able to establish MCID values because of nonsignificant relationships between the global recovery/rating scales and functional changes using the MAL,<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr76-1545968312461719">76</xref></sup> Wolf (time component),<sup><xref ref-type="bibr" rid="bibr63-1545968312461719">63</xref>,<xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> and accelerometry<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref></sup> (<xref ref-type="table" rid="table1-1545968312461719">Table 1</xref>).</p>
</sec>
<sec id="section11-1545968312461719">
<title>Detectable Change</title>
<p>Values needed to surpass measurement error, which are considered to represent true functional change (SEM, MDC<sub>90</sub>, MDC<sub>95</sub>, and limit of agreement values), were extracted or calculated from 16 studies for 9 measures.<sup><xref ref-type="bibr" rid="bibr12-1545968312461719">12</xref>,<xref ref-type="bibr" rid="bibr14-1545968312461719">14</xref>,<xref ref-type="bibr" rid="bibr15-1545968312461719">15</xref>,<xref ref-type="bibr" rid="bibr27-1545968312461719">27</xref>,<xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref><xref ref-type="bibr" rid="bibr67-1545968312461719"/><xref ref-type="bibr" rid="bibr68-1545968312461719"/><xref ref-type="bibr" rid="bibr69-1545968312461719"/><xref ref-type="bibr" rid="bibr70-1545968312461719"/><xref ref-type="bibr" rid="bibr71-1545968312461719"/><xref ref-type="bibr" rid="bibr72-1545968312461719"/><xref ref-type="bibr" rid="bibr73-1545968312461719"/><xref ref-type="bibr" rid="bibr74-1545968312461719"/><xref ref-type="bibr" rid="bibr75-1545968312461719"/><xref ref-type="bibr" rid="bibr76-1545968312461719"/>-<xref ref-type="bibr" rid="bibr77-1545968312461719">77</xref></sup> All studies used a test-retest methodology in which time frames in between assessments ranged from 1 day to 2 weeks; 9 studies used individuals with subacute stroke,<sup><xref ref-type="bibr" rid="bibr14-1545968312461719">14</xref>,<xref ref-type="bibr" rid="bibr15-1545968312461719">15</xref>,<xref ref-type="bibr" rid="bibr27-1545968312461719">27</xref>,<xref ref-type="bibr" rid="bibr68-1545968312461719">68</xref><xref ref-type="bibr" rid="bibr69-1545968312461719"/>-<xref ref-type="bibr" rid="bibr70-1545968312461719">70</xref>,<xref ref-type="bibr" rid="bibr72-1545968312461719">72</xref><xref ref-type="bibr" rid="bibr73-1545968312461719"/>-<xref ref-type="bibr" rid="bibr74-1545968312461719">74</xref></sup> and 7 studies used patients with chronic stroke.<sup><xref ref-type="bibr" rid="bibr12-1545968312461719">12</xref>,<xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref>,<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref>,<xref ref-type="bibr" rid="bibr71-1545968312461719">71</xref>,<xref ref-type="bibr" rid="bibr75-1545968312461719">75</xref><xref ref-type="bibr" rid="bibr76-1545968312461719"/>-<xref ref-type="bibr" rid="bibr77-1545968312461719">77</xref></sup> Also, 9 studies used a subsample of individuals from CIMT/forced-use trials<sup><xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref><xref ref-type="bibr" rid="bibr67-1545968312461719"/><xref ref-type="bibr" rid="bibr68-1545968312461719"/><xref ref-type="bibr" rid="bibr69-1545968312461719"/><xref ref-type="bibr" rid="bibr70-1545968312461719"/><xref ref-type="bibr" rid="bibr71-1545968312461719"/>-<xref ref-type="bibr" rid="bibr72-1545968312461719">72</xref>,<xref ref-type="bibr" rid="bibr76-1545968312461719">76</xref>,<xref ref-type="bibr" rid="bibr77-1545968312461719">77</xref></sup> of which 4 were from the EXCITE trial.<sup><xref ref-type="bibr" rid="bibr68-1545968312461719">68</xref><xref ref-type="bibr" rid="bibr69-1545968312461719"/>-<xref ref-type="bibr" rid="bibr70-1545968312461719">70</xref>,<xref ref-type="bibr" rid="bibr72-1545968312461719">72</xref></sup></p>
<p>MDC values at the 90% and 95% confidence levels ranged from 1.0% and 1.2% of the maximum score for the AMAT time subscale to 21.9% and 25.9% of the maximum score for the SIS hand, respectively. Relative to their sample means, MDC values at the 90% and 95% confidence levels ranged from 11.5% and 13.7% for the Wolf functional ability subscale to 72.5% and 86.7% for the MAL amount of use subscale, respectively. Detailed SEM, MDC<sub>90</sub>, and MDC<sub>95</sub> estimates and their respective relative percentage values (ie, relative to the sample mean or relative to the scale maximum score) can be found in Supplementary Table 3 available online. Among the measures with multiple estimates, the values needed to surpass measurement error for tools that capture patient-perceived function (eg, MAL, SIS) were larger than laboratory-based performance measures (eg, Wolf, Chedoke Arm and Hand Inventory; <xref ref-type="fig" rid="fig5-1545968312461719">Figure 5</xref>). This observation was present whether the MDC values were considered relative to the scale maximums or the sample means.</p>
<fig id="fig5-1545968312461719" position="float">
<label>Figure 5.</label>
<caption>
<p>Comparison of detectable change (calculated at 95% confidence level) relative to the sample means and scale maximums. The bars beside each measure represent the range of MDC<sub>95</sub>% values extracted or calculated from different studies. *Two studies analyzed different subsets of the same sample to obtain multiple estimates. †Estimates for the ARAT, Wolf (FAS), and SIS are missing from this graph because sample means were not provided in 2 studies.<sup><xref ref-type="bibr" rid="bibr12-1545968312461719">12</xref>,<xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup></p>
<p>Abbreviations: MDC<sub>95</sub>%, Minimally detectable change (with a 95% confidence interval) expressed as a percentage of A, the scale maximum score, and B, the sample means; MAL, Motor Activity Log; AOU, Amount of Use Scale; SIS, Stroke Impact Scale (hand); QOM, Quality of Movement Scale; TEMPA, Upper Extremity Performance Scale for the Elderly; AMAT, Arm Motor Ability Test; FAS, Functional Ability Scale; Duruoz, Duruoz Hand Index; Wolf, Wolf Motor Function Test; CAHAI, Chedoke Arm and Hand Activity Inventory; ARAT, Action Research Arm Test.</p>
</caption>
<graphic xlink:href="10.1177_1545968312461719-fig5.tif"/></fig>
<p>Also, the values needed to surpass measurement error for patient-perceived performance measures were larger or on par with important change values. For instance, MDC and important change values for the SIS were as follows: 17.1 to 21.9 (MDC<sub>90</sub>) and 20.4 to 25.9 (MDC<sub>95</sub>) versus 5.8 (distribution-based MCID) or 17.8 (anchor-based MCID). MDC and important change values for the MAL were as follows: 0.56 to 1.06 (MDC<sub>90</sub>) and 0.67 to 1.27 (MDC<sub>95</sub>) versus 1.0 to 1.1 (anchor-based MCID).</p>
</sec>
</sec>
<sec id="section12-1545968312461719" sec-type="discussion">
<title>Discussion</title>
<p>Examining the measurement of change in UE function served as a framework for understanding the measurement of functional recovery following stroke and revealed several novel findings related to the ability of outcome measures to capture change as it occurs.</p>
<sec id="section13-1545968312461719">
<title>Observed Change</title>
<p>For equal duration of follow-up, the effect sizes for natural recovery calculated at 1 to 3 months poststroke were substantially larger than those calculated at 3 months or later poststroke. The observed differences in effect sizes between these time phases likely reflect the higher degree of neuroplasticity, which has been documented early after stroke.<sup><xref ref-type="bibr" rid="bibr80-1545968312461719">80</xref></sup> The effect sizes obtained in the RCTs using a population at &gt;6 months poststroke ranged from 0.05 to 4.28, demonstrating that individuals are still capable of change at later time periods poststroke when receiving treatment. Of importance, our collective data demonstrate that rehabilitation treatments can affect patient perceptions of functional change as effectively as laboratory-based functional measures. In fact, CIMT is an exemplary treatment model where patient perceptions of change (MAL) were 1.6 to 6.2 times larger than effect sizes obtained with laboratory-based functional performance measures (ARAT or Wolf). A likely explanation is that CIMT was specifically designed to overcome learned nonuse, thereby targeting functional change in one’s own environment. Additionally, the higher relative effect sizes observed in the MAL following CIMT could also reflect patient bias. This bias could be present because of the large investment of time and effort required from the CIMT program. Finally, it should be noted that our observations concerning the relative ability of treatments to affect laboratory-based versus patient-perceived function may be limited to studies able to capture statistically significant effects.</p>
<p>Real-time accelerometry monitoring of UE activity in the home and community is a promising technology to objectively capture function in one’s own environment without the necessity of self-report.<sup><xref ref-type="bibr" rid="bibr81-1545968312461719">81</xref></sup> However, only 1 study provided an estimate of true or important change for accelerometry measures. More studies are needed to better understand the usefulness of real-time activity monitors for capturing the effectiveness of UE rehabilitation interventions.</p>
<p>The influence of the method used to calculate effect sizes (ie, methods based on baseline standard deviation versus standard deviation of the change scores) was also revealed. Methods based on the change score standard deviation (ie, standardized response mean) produced estimates that were up to 1.2 to 1.9 times larger than those calculated based on the baseline standard deviation (ie, population effect size). The method of effect size calculation is an important contextual factor that must be considered when designing and interpreting research. This has particular importance for interpreting treatment effects and when performing sample size calculations. The observed influence of the calculation method also highlights the difficulty of using an effect size in isolation when making a judgment about a measure’s general responsiveness.<sup><xref ref-type="bibr" rid="bibr82-1545968312461719">82</xref></sup></p>
</sec>
<sec id="section14-1545968312461719">
<title>Important Change</title>
<p>A key finding was that important change values obtained through anchor-based methods (eg, based on patient opinion or comparative measures) were higher than those for the distribution methods (eg, statistical estimates) among the studies that used both approaches.<sup><xref ref-type="bibr" rid="bibr65-1545968312461719">65</xref><xref ref-type="bibr" rid="bibr66-1545968312461719"/>-<xref ref-type="bibr" rid="bibr67-1545968312461719">67</xref></sup> In fact, the MCID of 1 measure (SIS) tripled in magnitude from the distribution-based to the anchor-based approach using the same participants.<sup><xref ref-type="bibr" rid="bibr66-1545968312461719">66</xref></sup> Our results indicate that distribution methods result in smaller MCID, and researchers may be tempted to interpret their findings in light of this MCID, especially if the intervention has small effects. However, statistically driven distribution methods have been criticized for their lack of meaning to participants.<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref>,<xref ref-type="bibr" rid="bibr83-1545968312461719">83</xref></sup> The MCID values from anchor-based approaches are larger and may provide a challenge in finding therapies that can achieve this effect. Some have questioned whether it is realistic to achieve MCID values derived from patient-perceived global rating scales (anchor-based) because many factors (eg, recall bias, baseline characteristics, expectations of treatment, and question format) can affect patients’ perception of change.<sup><xref ref-type="bibr" rid="bibr64-1545968312461719">64</xref>,<xref ref-type="bibr" rid="bibr84-1545968312461719">84</xref></sup> It has been suggested that a combination of anchor-based methods from patient and clinical perspectives be used to determine a MCID value, and distribution-based methods should only supplement this information.<sup><xref ref-type="bibr" rid="bibr83-1545968312461719">83</xref></sup></p>
</sec>
<sec id="section15-1545968312461719">
<title>Minimal Detectable Change</title>
<p>This synthesis highlighted important differences between laboratory-based and participant-perceived functional measures. Measures that capture perceived function in one’s own environment (eg, SIS, MAL) required larger values to surpass their measurement error than laboratory-based performance measures (eg, Wolf, ARAT). Although incorporating patient perspectives of functional change is an important component of capturing meaningful outcomes in neurorehabilitation research,<sup><xref ref-type="bibr" rid="bibr85-1545968312461719">85</xref></sup> researchers should be aware of the larger sample size required to be able to capture true change using perceived function measures. Quality criteria guidelines recommend that the values needed to surpass measurement error calculated at a 95% confidence interval (ie, true change captured by MDC<sub>95</sub>) should be less than the minimum values considered to be important (ie, MCID).<sup><xref ref-type="bibr" rid="bibr86-1545968312461719">86</xref></sup> In contrast, our study found that the MDC<sub>95</sub> and MDC<sub>90</sub> for patient-perceived functional measures (eg, MAL, SIS) were similar or greater than the MCID. There remains debate in the literature, however, concerning the best estimate of MDC values for self-report measures. Some researchers argue that MDC<sub>90</sub> and MDC<sub>95</sub> produce overly conservative estimates and recommend setting the MDC to 1 SEM.<sup><xref ref-type="bibr" rid="bibr87-1545968312461719">87</xref>,<xref ref-type="bibr" rid="bibr88-1545968312461719">88</xref></sup></p>
<p>One of the limitations of this article is that there is no one standard approach for conceptualizing responsiveness. We used the broad taxonomy described by Beaton et al.<sup><xref ref-type="bibr" rid="bibr1-1545968312461719">1</xref></sup> One international group (COSMIN) defined a narrower conceptualization of responsiveness, which used a longitudinal validity approach such as correlating change with an external criterion or determining the area under the receiver operating characteristic curve to distinguish between known groups.<sup><xref ref-type="bibr" rid="bibr82-1545968312461719">82</xref></sup> In addition, whereas there are established appraisal guidelines for intervention studies (eg, PeDRO Score), consensus has yet to be reached with regard to assessing the rigor of studies that measure an outcome measure’s psychometric properties. Application of the Beaton taxonomy, which focuses on the nature of the change, provided a useful framework for understanding the state of the stroke literature in regard to the broader topic of measuring functional change. Effect sizes provided in this study can inform hypotheses for future responsiveness testing. Finally, ceiling and floor effects were also not considered in this review. Large ceiling and/or floor effects may indicate that there is a subsection of the population for which measures are not as responsive and is another factor that can bias estimates of important change values.<sup><xref ref-type="bibr" rid="bibr89-1545968312461719">89</xref></sup> Given the contextual nature of responsiveness, the dominance of CIMT among the included studies should be noted. Samples from CIMT trials made up 80% of the important change articles, 56% of the detectable change articles, and 50% of the RCTs used to examine observed change in response to an effective treatment. Thus, the literature informing the ability of measurement tools to capture functional change in the UE poststroke may be biased in favor of those individuals who are eligible for CIMT trials.</p>
</sec></sec>
<sec id="section16-1545968312461719" sec-type="conclusions">
<title>Conclusions</title>
<p>In summary, this synthesis revealed important findings that have implications for the measurement and interpretation of UE functional recovery following stroke. The magnitude of important change or change that surpasses measurement error varied substantially depending on the method of calculation used. Our findings suggest that rehabilitation treatments can affect patient perceptions of functional change as effectively as laboratory-based functional measures; however, research studies may require higher sample sizes to account for the larger measurement error associated with patient-perceived functional measures. Future studies examining meaningful change in UE function in varied subgroups of individuals (ie, at different levels of stroke severity and stage of recovery) are needed.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by funding from the Canadian Health Institute of Research (CIHR MSH-63617) and Michael Smith Foundation of Health Research (JJE).</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1545968312461719">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beaton</surname><given-names>DE</given-names></name>
<name><surname>Bombardier</surname><given-names>C</given-names></name>
<name><surname>Katz</surname><given-names>JN</given-names></name>
<name><surname>Wright</surname><given-names>JG</given-names></name>
</person-group>. <article-title>A taxonomy for responsiveness</article-title>. <source>J Clin Epidemiol</source>. <year>2001</year>;<volume>54</volume>:<fpage>1204</fpage>-<lpage>1217</lpage>.</citation>
</ref>
<ref id="bibr2-1545968312461719">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mokkink</surname><given-names>LB</given-names></name>
<name><surname>Terwee</surname><given-names>CB</given-names></name>
<name><surname>Patrick</surname><given-names>DL</given-names></name><etal/>
</person-group>. <article-title>The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes</article-title>. <source>J Clin Epidemiol</source>. <year>2010</year>;<volume>63</volume>:<fpage>737</fpage>-<lpage>745</lpage>.</citation>
</ref>
<ref id="bibr3-1545968312461719">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kain</surname><given-names>ZN</given-names></name>
<name><surname>MacLaren</surname><given-names>J</given-names></name>
</person-group>. <article-title><italic>P</italic> less than .05: what does it really mean?</article-title> <source>Pediatrics</source>. <year>2007</year>;<volume>119</volume>:<fpage>608</fpage>.</citation>
</ref>
<ref id="bibr4-1545968312461719">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hopewell</surname><given-names>S</given-names></name>
<name><surname>Clarke</surname><given-names>M</given-names></name>
<name><surname>Lefebvre</surname><given-names>C</given-names></name>
<name><surname>Scherer</surname><given-names>R</given-names></name>
</person-group>. <article-title>Handsearching versus electronic searching to identify reports of randomized trials</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2007</year>;(<issue>2</issue>):<fpage>MR000001</fpage>.</citation>
</ref>
<ref id="bibr5-1545968312461719">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morris</surname><given-names>SB</given-names></name>
<name><surname>DeShon</surname><given-names>RP</given-names></name>
</person-group>. <article-title>Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs</article-title>. <source>Psychol Methods</source>. <year>2002</year>;<volume>7</volume>:<fpage>105</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr6-1545968312461719">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stratford</surname><given-names>PW</given-names></name>
</person-group>. <article-title>Getting more from the literature: estimating the standard error of measurement from reliability studies</article-title>. <source>Physiother Can</source>. <year>2004</year>;<volume>56</volume>:<fpage>27</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr7-1545968312461719">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Flansbjer</surname><given-names>UB</given-names></name>
<name><surname>Holmbäck</surname><given-names>AM</given-names></name>
<name><surname>Downham</surname><given-names>D</given-names></name>
<name><surname>Patten</surname><given-names>C</given-names></name>
<name><surname>Lexell</surname><given-names>J</given-names></name>
</person-group>. <article-title>Reliability of gait performance tests in men and women with hemiparesis after stroke</article-title>. <source>J Rehabil Med</source>. <year>2005</year>;<volume>37</volume>:<fpage>75</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr8-1545968312461719">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Angst</surname><given-names>F</given-names></name>
</person-group>. <article-title>The new COSMIN guidelines confront traditional concepts of responsiveness</article-title>. <source>BMC Med Res Methodol</source>. <year>2011</year>;<volume>11</volume>:<fpage>152</fpage>.</citation>
</ref>
<ref id="bibr9-1545968312461719">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hozo</surname><given-names>S</given-names></name>
<name><surname>Djulbegovic</surname><given-names>B</given-names></name>
<name><surname>Hozo</surname><given-names>I</given-names></name>
</person-group>. <article-title>Estimating the mean and variance from the median, range, and the size of a sample</article-title>. <source>BMC Med Res Methodol</source>. <year>2005</year>;<volume>5</volume>:<fpage>13</fpage>.</citation>
</ref>
<ref id="bibr10-1545968312461719">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beebe</surname><given-names>JA</given-names></name>
<name><surname>Lang</surname><given-names>CE</given-names></name>
</person-group>. <article-title>Relationships and responsiveness of six upper extremity function tests during the first six months of recovery after stroke</article-title>. <source>J Neurol Phys Ther</source>. <year>2009</year>;<volume>33</volume>:<fpage>96</fpage>-<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr11-1545968312461719">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsueh</surname><given-names>I</given-names></name>
<name><surname>Hsieh</surname><given-names>C</given-names></name>
</person-group>. <article-title>Responsiveness of two upper extremity function instruments for stroke inpatients receiving rehabilitation</article-title>. <source>Clin Rehabil</source>. <year>2002</year>;<volume>16</volume>:<fpage>617</fpage>-<lpage>624</lpage>.</citation>
</ref>
<ref id="bibr12-1545968312461719">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>JH</given-names></name>
<name><surname>Hsu</surname><given-names>MJ</given-names></name>
<name><surname>Sheu</surname><given-names>CF</given-names></name><etal/>
</person-group>. <article-title>Psychometric comparisons of 4 measures for assessing upper-extremity function in people with stroke</article-title>. <source>Phys Ther</source>. <year>2009</year>;<volume>89</volume>:<fpage>840</fpage>-<lpage>850</lpage>.</citation>
</ref>
<ref id="bibr13-1545968312461719">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rabadi</surname><given-names>MH</given-names></name>
<name><surname>Rabadi</surname><given-names>FM</given-names></name>
</person-group>. <article-title>Comparison of the Action Research Arm Test and the Fugl-Meyer assessment as measures of upper-extremity motor weakness after stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2006</year>;<volume>87</volume>:<fpage>962</fpage>-<lpage>966</lpage>.</citation>
</ref>
<ref id="bibr14-1545968312461719">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barreca</surname><given-names>SR</given-names></name>
<name><surname>Stratford</surname><given-names>PW</given-names></name>
<name><surname>Masters</surname><given-names>LM</given-names></name>
<name><surname>Lambert</surname><given-names>CL</given-names></name>
<name><surname>Griffiths</surname><given-names>J</given-names></name>
<name><surname>McBay</surname><given-names>C</given-names></name>
</person-group>. <article-title>Validation of three shortened versions of the Chedoke Arm and Hand Activity Inventory</article-title>. <source>Physiother Can</source>. <year>2006</year>;<volume>58</volume>:<fpage>148</fpage>-<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr15-1545968312461719">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barreca</surname><given-names>SR</given-names></name>
<name><surname>Stratford</surname><given-names>PW</given-names></name>
<name><surname>Lambert</surname><given-names>CL</given-names></name>
<name><surname>Masters</surname><given-names>LM</given-names></name>
<name><surname>Streiner</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Test-retest reliability, validity, and sensitivity of the Chedoke Arm and Hand Activity Inventory: a new measure of upper-limb function for survivors of stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2005</year>;<volume>86</volume>:<fpage>1616</fpage>-<lpage>1622</lpage>.</citation>
</ref>
<ref id="bibr16-1545968312461719">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barreca</surname><given-names>SR</given-names></name>
<name><surname>Stratford</surname><given-names>PW</given-names></name>
<name><surname>Masters</surname><given-names>LM</given-names></name>
<name><surname>Lambert</surname><given-names>CL</given-names></name>
<name><surname>Griffiths</surname><given-names>J</given-names></name>
</person-group>. <article-title>Comparing 2 versions of the Chedoke Arm and Hand Activity Inventory with the Action Research Arm Test</article-title>. <source>Phys Ther</source>. <year>2006</year>;<volume>86</volume>:<fpage>245</fpage>-<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr17-1545968312461719">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pandyan</surname><given-names>AD</given-names></name>
<name><surname>Cameron</surname><given-names>M</given-names></name>
<name><surname>Powell</surname><given-names>J</given-names></name>
<name><surname>Stott</surname><given-names>DJ</given-names></name>
<name><surname>Granat</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Contractures in the post-stroke wrist: a pilot study of its time course of development and its association with upper limb recovery</article-title>. <source>Clin Rehabil</source>. <year>2003</year>;<volume>17</volume>:<fpage>88</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr18-1545968312461719">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brunner</surname><given-names>IC</given-names></name>
<name><surname>Skouen</surname><given-names>JS</given-names></name>
<name><surname>Strand</surname><given-names>LI</given-names></name>
</person-group>. <article-title>Recovery of upper extremity motor function post stroke with regard to eligibility for constraint-induced movement therapy</article-title>. <source>Top Stroke Rehabil</source>. <year>2011</year>;<volume>18</volume>:<fpage>248</fpage>-<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr19-1545968312461719">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Au-Yeung</surname><given-names>SS</given-names></name>
<name><surname>Hui-Chan</surname><given-names>CW</given-names></name>
</person-group>. <article-title>Predicting recovery of dextrous hand function in acute stroke</article-title>. <source>Disabil Rehabil</source>. <year>2009</year>;<volume>31</volume>:<fpage>394</fpage>-<lpage>401</lpage>.</citation>
</ref>
<ref id="bibr20-1545968312461719">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rand</surname><given-names>D</given-names></name>
<name><surname>Eng</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Disparity between functional recovery and daily use of the upper and lower extremities during subacute stroke rehabilitation</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2012</year>;<volume>26</volume>:<fpage>76</fpage>-<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr21-1545968312461719">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roiha</surname><given-names>K</given-names></name>
<name><surname>Kirveskari</surname><given-names>E</given-names></name>
<name><surname>Kaste</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Reorganization of the primary somatosensory cortex during stroke recovery</article-title>. <source>Clin Neurophysiol</source>. <year>2011</year>;<volume>122</volume>:<fpage>339</fpage>-<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr22-1545968312461719">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blennerhassett</surname><given-names>JM</given-names></name>
<name><surname>Avery</surname><given-names>RM</given-names></name>
<name><surname>Carey</surname><given-names>LM</given-names></name>
</person-group>. <article-title>The test-retest reliability and responsiveness to change for the Hand Function Survey during stroke rehabilitation</article-title>. <source>Aust Occup Ther J</source>. <year>2010</year>;<volume>57</volume>:<fpage>431</fpage>-<lpage>438</lpage>.</citation>
</ref>
<ref id="bibr23-1545968312461719">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rehme</surname><given-names>AK</given-names></name>
<name><surname>Fink</surname><given-names>GR</given-names></name>
<name><surname>von Cramon</surname><given-names>DY</given-names></name>
<name><surname>Grefkes</surname><given-names>C</given-names></name>
</person-group>. <article-title>The role of the contralesional motor cortex for motor recovery in the early days after stroke assessed with longitudinal FMRI</article-title>. <source>Cereb Cortex</source>. <year>2011</year>;<volume>21</volume>:<fpage>756</fpage>-<lpage>768</lpage>.</citation>
</ref>
<ref id="bibr24-1545968312461719">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Filiatrault</surname><given-names>J</given-names></name>
<name><surname>Arsenault</surname><given-names>AB</given-names></name>
<name><surname>Dutil</surname><given-names>E</given-names></name>
<name><surname>Bourbonnais</surname><given-names>D</given-names></name>
</person-group>. <article-title>Motor function and activities of daily living assessments: a study of three tests for persons with hemiplegia</article-title>. <source>Am J Occup Ther</source>. <year>1991</year>;<volume>45</volume>:<fpage>806</fpage>-<lpage>810</lpage>.</citation>
</ref>
<ref id="bibr25-1545968312461719">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duncan</surname><given-names>PW</given-names></name>
<name><surname>Wallace</surname><given-names>D</given-names></name>
<name><surname>Lai</surname><given-names>SM</given-names></name>
<name><surname>Johnson</surname><given-names>D</given-names></name>
<name><surname>Embretson</surname><given-names>S</given-names></name>
<name><surname>Laster</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>The Stroke Impact Scale version 2.0. Evaluation of reliability, validity, and sensitivity to change</article-title>. <source>Stroke</source>. <year>1999</year>;<volume>30</volume>:<fpage>2131</fpage>-<lpage>2140</lpage>.</citation>
</ref>
<ref id="bibr26-1545968312461719">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kamel</surname><given-names>A</given-names></name>
<name><surname>Ghani</surname><given-names>AA</given-names></name>
<name><surname>Zaiton</surname><given-names>MA</given-names></name>
<name><surname>El-Motayam</surname><given-names>AS</given-names></name>
<name><surname>El-Fattah</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Health related quality of life in stroke survivors measured by the Stroke Impact Scale</article-title>. <source>Egypt J Neurol Psychiatry Neurosurg</source>. <year>2010</year>;<volume>47</volume>:<fpage>267</fpage>-<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr27-1545968312461719">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sezer</surname><given-names>N</given-names></name>
<name><surname>Yavuzer</surname><given-names>G</given-names></name>
<name><surname>Sivrioglu</surname><given-names>K</given-names></name>
<name><surname>Basaran</surname><given-names>P</given-names></name>
<name><surname>Koseoglu</surname><given-names>BF</given-names></name>
</person-group>. <article-title>Clinimetric properties of the Duruoz Hand Index in patients with stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2007</year>;<volume>88</volume>:<fpage>309</fpage>-<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr28-1545968312461719">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bouffioulx</surname><given-names>É</given-names></name>
<name><surname>Arnould</surname><given-names>C</given-names></name>
<name><surname>Thonnard</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Satisfaction with activity and participation and its relationships with body functions, activities, or environmental factors in stroke patients</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2011</year>;<volume>92s</volume>:<fpage>1404</fpage>-<lpage>1410</lpage>.</citation>
</ref>
<ref id="bibr29-1545968312461719">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rand</surname><given-names>D</given-names></name>
<name><surname>Gottlieb</surname><given-names>D</given-names></name>
<name><surname>Weiss</surname><given-names>P</given-names></name>
</person-group>. <article-title>Recovery of patients with a combined motor and proprioception deficit during the first six weeks of post stroke rehabilitation</article-title>. <source>Phys Occup Ther Geriatr</source>. <year>2001</year>;<volume>18</volume>:<fpage>69</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr30-1545968312461719">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wittenberg</surname><given-names>GF</given-names></name>
<name><surname>Bastings</surname><given-names>EP</given-names></name>
<name><surname>Fowlkes</surname><given-names>AM</given-names></name>
<name><surname>Morgan</surname><given-names>TM</given-names></name>
<name><surname>Good</surname><given-names>DC</given-names></name>
<name><surname>Pons</surname><given-names>TP</given-names></name>
</person-group>. <article-title>Dynamic course of intracortical TMS paired-pulse responses during recovery of motor function after stroke</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2007</year>;<volume>21</volume>:<fpage>568</fpage>-<lpage>573</lpage>.</citation>
</ref>
<ref id="bibr31-1545968312461719">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>J</given-names></name>
<name><surname>Mayo</surname><given-names>NE</given-names></name>
<name><surname>Desrosiers</surname><given-names>J</given-names></name>
<name><surname>Salbach</surname><given-names>NM</given-names></name>
<name><surname>Ahmed</surname><given-names>S</given-names></name>
</person-group>. <article-title>Upper-limb function and recovery in the acute phase poststroke</article-title>. <source>J Rehabil Res Dev</source>. <year>2005</year>;<volume>42</volume>:<fpage>65</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr32-1545968312461719">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayo</surname><given-names>NE</given-names></name>
<name><surname>Wood-Dauphinee</surname><given-names>S</given-names></name>
<name><surname>Ahmed</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Disablement following stroke</article-title>. <source>Disabil Rehabil</source>. <year>1999</year>;<volume>21</volume>:<fpage>258</fpage>-<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr33-1545968312461719">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Desrosiers</surname><given-names>J</given-names></name>
<name><surname>Malouin</surname><given-names>F</given-names></name>
<name><surname>Richards</surname><given-names>C</given-names></name>
<name><surname>Bourbonnais</surname><given-names>D</given-names></name>
<name><surname>Rochette</surname><given-names>A</given-names></name>
<name><surname>Bravo</surname><given-names>G</given-names></name>
</person-group>. <article-title>Comparison of changes in upper and lower extremity impairments and disabilities after stroke</article-title>. <source>Int J Rehabil Res</source>. <year>2003</year>;<volume>26</volume>:<fpage>109</fpage>-<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr34-1545968312461719">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feydy</surname><given-names>A</given-names></name>
<name><surname>Carlier</surname><given-names>R</given-names></name>
<name><surname>Roby-Brami</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Longitudinal study of motor recovery after stroke: Recruitment and focusing of brain activation</article-title>. <source>Stroke</source>. <year>2002</year>;<volume>33</volume>:<fpage>1610</fpage>-<lpage>1617</lpage>.</citation>
</ref>
<ref id="bibr35-1545968312461719">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsu</surname><given-names>SS</given-names></name>
<name><surname>Hu</surname><given-names>MH</given-names></name>
<name><surname>Wang</surname><given-names>YH</given-names></name>
<name><surname>Yip</surname><given-names>PK</given-names></name>
<name><surname>Chiu</surname><given-names>JW</given-names></name>
<name><surname>Hsieh</surname><given-names>CL</given-names></name>
</person-group>. <article-title>Dose-response relation between neuromuscular electrical stimulation and upper-extremity function in patients with stroke</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>:<fpage>821</fpage>-<lpage>824</lpage>.</citation>
</ref>
<ref id="bibr36-1545968312461719">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Page</surname><given-names>SJ</given-names></name>
<name><surname>Levine</surname><given-names>P</given-names></name>
<name><surname>Leonard</surname><given-names>AC</given-names></name>
</person-group>. <article-title>Modified constraint-induced therapy in acute stroke: a randomized controlled pilot study</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2005</year>;<volume>19</volume>:<fpage>27</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr37-1545968312461719">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname><given-names>SF</given-names></name>
<name><surname>Hsu</surname><given-names>CW</given-names></name>
<name><surname>Sun</surname><given-names>HP</given-names></name>
<name><surname>Hwang</surname><given-names>CW</given-names></name>
<name><surname>Yang</surname><given-names>CL</given-names></name>
<name><surname>Wang</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2010</year>;<volume>24</volume>:<fpage>34</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr38-1545968312461719">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Myint</surname><given-names>JM</given-names></name>
<name><surname>Yuen</surname><given-names>GF</given-names></name>
<name><surname>Yu</surname><given-names>TK</given-names></name><etal/>
</person-group>. <article-title>A study of constraint-induced movement therapy in subacute stroke patients in Hong Kong</article-title>. <source>Clin Rehabil</source>. <year>2008</year>;<volume>22</volume>:<fpage>112</fpage>-<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr39-1545968312461719">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Lee</surname><given-names>JH</given-names></name>
<name><surname>Wagenaar</surname><given-names>RC</given-names></name>
<name><surname>Lankhorst</surname><given-names>GJ</given-names></name>
<name><surname>Vogelaar</surname><given-names>TW</given-names></name>
<name><surname>Deville</surname><given-names>WL</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial</article-title>. <source>Stroke</source>. <year>1999</year>;<volume>30</volume>:<fpage>2369</fpage>-<lpage>2375</lpage>.</citation>
</ref>
<ref id="bibr40-1545968312461719">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>JE</given-names></name>
<name><surname>Eng</surname><given-names>JJ</given-names></name>
<name><surname>Miller</surname><given-names>WC</given-names></name>
<name><surname>Dawson</surname><given-names>AS</given-names></name>
</person-group>. <article-title>A self-administered graded repetitive arm supplementary program (GRASP) improves arm function during inpatient stroke rehabilitation: a multi-site randomized controlled trial</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>:<fpage>2123</fpage>-<lpage>2128</lpage>.</citation>
</ref>
<ref id="bibr41-1545968312461719">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shindo</surname><given-names>K</given-names></name>
<name><surname>Fujiwara</surname><given-names>T</given-names></name>
<name><surname>Hara</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Effectiveness of hybrid assistive neuromuscular dynamic stimulation therapy in patients with subacute stroke</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2011</year>;<volume>25</volume>:<fpage>830</fpage>-<lpage>837</lpage>.</citation>
</ref>
<ref id="bibr42-1545968312461719">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dahl</surname><given-names>AE</given-names></name>
<name><surname>Askim</surname><given-names>T</given-names></name>
<name><surname>Stock</surname><given-names>R</given-names></name>
<name><surname>Langorgen</surname><given-names>E</given-names></name>
<name><surname>Lydersen</surname><given-names>S</given-names></name>
<name><surname>Indredavik</surname><given-names>B</given-names></name>
</person-group>. <article-title>Short- and long-term outcome of constraint-induced movement therapy after stroke: a randomized controlled feasibility trial</article-title>. <source>Clin Rehabil</source>. <year>2008</year>;<volume>22</volume>:<fpage>436</fpage>-<lpage>447</lpage>.</citation>
</ref>
<ref id="bibr43-1545968312461719">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cacchio</surname><given-names>A</given-names></name>
<name><surname>De Blasis</surname><given-names>E</given-names></name>
<name><surname>De Blasis</surname><given-names>V</given-names></name>
<name><surname>Santilli</surname><given-names>V</given-names></name>
<name><surname>Spacca</surname><given-names>G</given-names></name>
</person-group>. <article-title>Mirror therapy in complex regional pain syndrome type 1 of the upper limb in stroke patients</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>792</fpage>-<lpage>799</lpage>.</citation>
</ref>
<ref id="bibr44-1545968312461719">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kowalczewski</surname><given-names>J</given-names></name>
<name><surname>Gritsenko</surname><given-names>V</given-names></name>
<name><surname>Ashworth</surname><given-names>N</given-names></name>
<name><surname>Ellaway</surname><given-names>P</given-names></name>
<name><surname>Prochazka</surname><given-names>A</given-names></name>
</person-group>. <article-title>Upper-extremity functional electric stimulation-assisted exercises on a workstation in the subacute phase of stroke recovery</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2007</year>;<volume>88</volume>:<fpage>833</fpage>-<lpage>839</lpage>.</citation>
</ref>
<ref id="bibr45-1545968312461719">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pang</surname><given-names>MY</given-names></name>
<name><surname>Harris</surname><given-names>JE</given-names></name>
<name><surname>Eng</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>A community-based upper-extremity group exercise program improves motor function and performance of functional activities in chronic stroke: a randomized controlled trial</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2006</year>;<volume>87</volume>:<fpage>1</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr46-1545968312461719">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Uswatte</surname><given-names>G</given-names></name>
<name><surname>King</surname><given-names>DK</given-names></name>
<name><surname>Morris</surname><given-names>D</given-names></name>
<name><surname>Crago</surname><given-names>JE</given-names></name>
<name><surname>Chatterjee</surname><given-names>A</given-names></name>
</person-group>. <article-title>A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>:<fpage>1045</fpage>-<lpage>1049</lpage>.</citation>
</ref>
<ref id="bibr47-1545968312461719">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wittenberg</surname><given-names>GF</given-names></name>
<name><surname>Chen</surname><given-names>R</given-names></name>
<name><surname>Ishii</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2003</year>;<volume>17</volume>:<fpage>48</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr48-1545968312461719">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Chuang</surname><given-names>LL</given-names></name>
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Chen</surname><given-names>HC</given-names></name>
<name><surname>Tsay</surname><given-names>PK</given-names></name>
</person-group>. <article-title>Randomized trial of distributed constraint-induced therapy versus bilateral arm training for the rehabilitation of upper-limb motor control and function after stroke</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2011</year>;<volume>25</volume>:<fpage>130</fpage>-<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr49-1545968312461719">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gauthier</surname><given-names>LV</given-names></name>
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Perkins</surname><given-names>C</given-names></name>
<name><surname>Ortmann</surname><given-names>M</given-names></name>
<name><surname>Mark</surname><given-names>VW</given-names></name>
<name><surname>Uswatte</surname><given-names>G</given-names></name>
</person-group>. <article-title>Remodeling the brain: plastic structural brain changes produced by different motor therapies after stroke</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>:<fpage>1520</fpage>-<lpage>1525</lpage>.</citation>
</ref>
<ref id="bibr50-1545968312461719">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>CM</given-names></name>
<name><surname>Oesch</surname><given-names>PR</given-names></name>
<name><surname>Gamper</surname><given-names>UN</given-names></name>
<name><surname>Kool</surname><given-names>JP</given-names></name>
<name><surname>Beer</surname><given-names>S</given-names></name>
</person-group>. <article-title>Potential effectiveness of three different treatment approaches to improve minimal to moderate arm and hand function after stroke: a pilot randomized clinical trial</article-title>. <source>Clin Rehabil</source>. <year>2011</year>;<volume>25</volume>:<fpage>1032</fpage>-<lpage>1041</lpage>.</citation>
</ref>
<ref id="bibr51-1545968312461719">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tariah</surname><given-names>HA</given-names></name>
<name><surname>Almalty</surname><given-names>A</given-names></name>
<name><surname>Sbeih</surname><given-names>Z</given-names></name>
<name><surname>Al-Oraibi</surname><given-names>S</given-names></name>
<name><surname>Bernhardt</surname><given-names>J</given-names></name>
<name><surname>Rowe</surname><given-names>V</given-names></name>
</person-group>. <article-title>Constraint induced movement therapy for stroke survivors in Jordon: a home-based model</article-title>. <source>Int J Ther Rehabil</source>. <year>2010</year>;<volume>17</volume>:<fpage>638</fpage>-<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr52-1545968312461719">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dromerick</surname><given-names>AW</given-names></name>
<name><surname>Lang</surname><given-names>CE</given-names></name>
<name><surname>Birkenmeier</surname><given-names>RL</given-names></name><etal/>
</person-group>. <article-title>Very early constraint-induced movement during stroke rehabilitation (VECTORS): a single-center RCT</article-title>. <source>Neurology</source>. <year>2009</year>;<volume>73</volume>:<fpage>195</fpage>-<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr53-1545968312461719">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Church</surname><given-names>C</given-names></name>
<name><surname>Price</surname><given-names>C</given-names></name>
<name><surname>Pandyan</surname><given-names>AD</given-names></name>
<name><surname>Huntley</surname><given-names>S</given-names></name>
<name><surname>Curless</surname><given-names>R</given-names></name>
<name><surname>Rodgers</surname><given-names>H</given-names></name>
</person-group>. <article-title>Randomized controlled trial to evaluate the effect of surface neuromuscular electrical stimulation to the shoulder after acute stroke</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>:<fpage>2995</fpage>-<lpage>3001</lpage>.</citation>
</ref>
<ref id="bibr54-1545968312461719">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Chen</surname><given-names>CL</given-names></name>
<name><surname>Tsai</surname><given-names>WC</given-names></name>
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Chou</surname><given-names>SH</given-names></name>
</person-group>. <article-title>A randomized controlled trial of modified constraint-induced movement therapy for elderly stroke survivors: changes in motor impairment, daily functioning, and quality of life</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2007</year>;<volume>88</volume>:<fpage>273</fpage>-<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr55-1545968312461719">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kimberley</surname><given-names>TJ</given-names></name>
<name><surname>Lewis</surname><given-names>SM</given-names></name>
<name><surname>Auerbach</surname><given-names>EJ</given-names></name>
<name><surname>Dorsey</surname><given-names>LL</given-names></name>
<name><surname>Lojovich</surname><given-names>JM</given-names></name> <name><surname>Carey</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Electrical stimulation driving functional improvements and cortical changes in subjects with stroke</article-title>. <source>Exp Brain Res</source>. <year>2004</year>;<volume>154</volume>:<fpage>450</fpage>-<lpage>460</lpage>.</citation>
</ref>
<ref id="bibr56-1545968312461719">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Chang</surname><given-names>YF</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Chen</surname><given-names>YA</given-names></name>
</person-group>. <article-title>Effects of constraint-induced therapy versus bilateral arm training on motor performance, daily functions, and quality of life in stroke survivors</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>441</fpage>-<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr57-1545968312461719">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Liu</surname><given-names>JS</given-names></name>
<name><surname>Chen</surname><given-names>YT</given-names></name>
<name><surname>Hsu</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Constraint-induced therapy versus dose-matched control intervention to improve motor ability, basic/extended daily functions, and quality of life in stroke</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>160</fpage>-<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr58-1545968312461719">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ertelt</surname><given-names>D</given-names></name>
<name><surname>Small</surname><given-names>S</given-names></name>
<name><surname>Solodkin</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Action observation has a positive impact on rehabilitation of motor deficits after stroke</article-title>. <source>Neuroimage</source>. <year>2007</year>;<volume>36</volume>:<fpage>T164</fpage>-<lpage>T173</lpage>.</citation>
</ref>
<ref id="bibr59-1545968312461719">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conroy</surname><given-names>SS</given-names></name>
<name><surname>Whitall</surname><given-names>J</given-names></name>
<name><surname>Dipietro</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Effect of gravity on robot-assisted motor training after chronic stroke: a randomized trial</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2011</year>;<volume>92</volume>:<fpage>1754</fpage>-<lpage>1761</lpage>.</citation>
</ref>
<ref id="bibr60-1545968312461719">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liao</surname><given-names>WW</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Hsieh</surname><given-names>YW</given-names></name>
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Chang</surname><given-names>WY</given-names></name>
</person-group>. <article-title>Effects of robot-assisted upper limb rehabilitation on daily function and real-world arm activity in patients with chronic stroke: a randomized controlled trial</article-title>. <source>Clin Rehabil</source>. <year>2012</year>;<volume>26</volume>:<fpage>111</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr61-1545968312461719">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Page</surname><given-names>SJ</given-names></name>
<name><surname>Levin</surname><given-names>L</given-names></name>
<name><surname>Hermann</surname><given-names>V</given-names></name>
<name><surname>Dunning</surname><given-names>K</given-names></name>
<name><surname>Levine</surname><given-names>P</given-names></name>
</person-group>. <article-title>Longer versus shorter daily durations of electrical stimulation during task-specific practice in moderately impaired stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2012</year>;<volume>93</volume>:<fpage>200</fpage>-<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr62-1545968312461719">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>YW</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Liao</surname><given-names>WW</given-names></name>
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Wu</surname><given-names>KY</given-names></name>
<name><surname>Lee</surname><given-names>CY</given-names></name>
</person-group>. <article-title>Effects of treatment intensity in upper limb robot-assisted therapy for chronic stroke: a pilot randomized controlled trial</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2011</year>;<volume>25</volume>:<fpage>503</fpage>-<lpage>511</lpage>.</citation>
</ref>
<ref id="bibr63-1545968312461719">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fritz</surname><given-names>SL</given-names></name>
<name><surname>George</surname><given-names>SZ</given-names></name>
<name><surname>Wolf</surname><given-names>SL</given-names></name>
<name><surname>Light</surname><given-names>KE</given-names></name>
</person-group>. <article-title>Participant perception of recovery as criterion to establish importance of improvement for constraint-induced movement therapy outcome measures: a preliminary study</article-title>. <source>Phys Ther</source>. <year>2007</year>;<volume>87</volume>:<fpage>170</fpage>-<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr64-1545968312461719">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lang</surname><given-names>CE</given-names></name>
<name><surname>Edwards</surname><given-names>DF</given-names></name>
<name><surname>Birkenmeier</surname><given-names>RL</given-names></name>
<name><surname>Dromerick</surname><given-names>AW</given-names></name>
</person-group>. <article-title>Estimating minimal clinically important differences of upper-extremity measures early after stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2008</year>;<volume>89</volume>:<fpage>1693</fpage>-<lpage>1700</lpage>.</citation>
</ref>
<ref id="bibr65-1545968312461719">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>TN</given-names></name>
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Chung</surname><given-names>CY</given-names></name>
<name><surname>Pei</surname><given-names>YC</given-names></name>
<name><surname>Teng</surname><given-names>YK</given-names></name>
</person-group>. <article-title>Validity, responsiveness, and clinically important difference of the ABILHAND questionnaire in patients with stroke</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2011</year>;<volume>92</volume>:<fpage>1086</fpage>-<lpage>1091</lpage>.</citation>
</ref>
<ref id="bibr66-1545968312461719">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Fu</surname><given-names>T</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name><etal/>
</person-group>. <article-title>Minimal detectable change and clinically important difference of the Stroke Impact Scale in stroke patients</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2010</year>;<volume>24</volume>:<fpage>486</fpage>-<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr67-1545968312461719">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>KC</given-names></name>
<name><surname>Hsieh</surname><given-names>YW</given-names></name>
<name><surname>Wu</surname><given-names>CY</given-names></name>
<name><surname>Chen</surname><given-names>CL</given-names></name>
<name><surname>Jang</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Minimal detectable change and clinically important difference of the Wolf Motor Function Test in stroke patients</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>429</fpage>-<lpage>434</lpage>.</citation>
</ref>
<ref id="bibr68-1545968312461719">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fritz</surname><given-names>SL</given-names></name>
<name><surname>Blanton</surname><given-names>S</given-names></name>
<name><surname>Uswatte</surname><given-names>G</given-names></name>
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Wolf</surname><given-names>SL</given-names></name>
</person-group>. <article-title>Minimal detectable change scores for the Wolf Motor Function Test</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>662</fpage>-<lpage>667</lpage>.</citation>
</ref>
<ref id="bibr69-1545968312461719">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolf</surname><given-names>SL</given-names></name>
<name><surname>Thompson</surname><given-names>PA</given-names></name>
<name><surname>Morris</surname><given-names>DM</given-names></name><etal/>
</person-group>. <article-title>The EXCITE trial: attributes of the Wolf Motor Function Test in patients with subacute stroke</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2005</year>;<volume>19</volume>:<fpage>194</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr70-1545968312461719">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uswatte</surname><given-names>G</given-names></name>
<name><surname>Giuliani</surname><given-names>C</given-names></name>
<name><surname>Winstein</surname><given-names>C</given-names></name>
<name><surname>Zeringue</surname><given-names>A</given-names></name>
<name><surname>Hobbs</surname><given-names>L</given-names></name>
<name><surname>Wolf</surname><given-names>SL</given-names></name>
</person-group>. <article-title>Validity of accelerometry for monitoring real-world arm activity in patients with subacute stroke: evidence from the extremity constraint-induced therapy evaluation trial</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2006</year>;<volume>87</volume>:<fpage>1340</fpage>-<lpage>1345</lpage>.</citation>
</ref>
<ref id="bibr71-1545968312461719">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uswatte</surname><given-names>G</given-names></name>
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Morris</surname><given-names>D</given-names></name>
<name><surname>Vignolo</surname><given-names>M</given-names></name>
<name><surname>McCulloch</surname><given-names>K</given-names></name>
</person-group>. <article-title>Reliability and validity of the upper-extremity Motor Activity Log-14 for measuring real-world arm use</article-title>. <source>Stroke</source>. <year>2005</year>;<volume>36</volume>:<fpage>2493</fpage>-<lpage>2496</lpage>.</citation>
</ref>
<ref id="bibr72-1545968312461719">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uswatte</surname><given-names>G</given-names></name>
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Morris</surname><given-names>D</given-names></name>
<name><surname>Light</surname><given-names>K</given-names></name>
<name><surname>Thompson</surname><given-names>PA</given-names></name>
</person-group>. <article-title>The Motor Activity Log-28: assessing daily use of the hemiparetic arm after stroke</article-title>. <source>Neurology</source>. <year>2006</year>;<volume>67</volume>:<fpage>1189</fpage>-<lpage>1194</lpage>.</citation>
</ref>
<ref id="bibr73-1545968312461719">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kopp</surname><given-names>B</given-names></name>
<name><surname>Kunkel</surname><given-names>A</given-names></name>
<name><surname>Flor</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>The Arm Motor Ability Test: reliability, validity, and sensitivity to change of an instrument for assessing disabilities in activities of daily living</article-title>. <source>Arch Phys Med Rehabil</source>. <year>1997</year>;<volume>78</volume>:<fpage>615</fpage>-<lpage>620</lpage>.</citation>
</ref>
<ref id="bibr74-1545968312461719">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richards</surname><given-names>L</given-names></name>
<name><surname>Stoker-Yates</surname><given-names>J</given-names></name>
<name><surname>Pohl</surname><given-names>P</given-names></name>
<name><surname>Wallace</surname><given-names>D</given-names></name>
<name><surname>Duncan</surname><given-names>P</given-names></name>
</person-group>. <article-title>Reliability and validity of two tests of upper extremity motor function post-stroke</article-title>. <source>Occup Ther J Res</source>. <year>2001</year>;<volume>21</volume>:<fpage>201</fpage>-<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr75-1545968312461719">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carod-Artal</surname><given-names>FJ</given-names></name>
<name><surname>Coral</surname><given-names>LF</given-names></name>
<name><surname>Trizotto</surname><given-names>DS</given-names></name>
<name><surname>Moreira</surname><given-names>CM</given-names></name>
</person-group>. <article-title>The Stroke Impact Scale 3.0: evaluation of acceptability, reliability, and validity of the Brazilian version</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>:<fpage>2477</fpage>-<lpage>2484</lpage>.</citation>
</ref>
<ref id="bibr76-1545968312461719">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Lee</surname><given-names>JH</given-names></name>
<name><surname>Beckerman</surname><given-names>H</given-names></name>
<name><surname>Knol</surname><given-names>DL</given-names></name>
<name><surname>De Vet</surname><given-names>HC</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Clinimetric properties of the Motor Activity Log for the assessment of arm use in hemiparetic patients</article-title>. <source>Stroke</source>. <year>2004</year>;<volume>35</volume>:<fpage>1410</fpage>.</citation>
</ref>
<ref id="bibr77-1545968312461719">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Lee</surname><given-names>JH</given-names></name>
<name><surname>Beckerman</surname><given-names>H</given-names></name>
<name><surname>Lankhorst</surname><given-names>GJ</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>The responsiveness of the Action Research Arm Test and the Fugl-Meyer assessment scale in chronic stroke patients</article-title>. <source>J Rehabil Med</source>. <year>2001</year>;<volume>33</volume>:<fpage>110</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr78-1545968312461719">
<label>78.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Streiner</surname><given-names>DL</given-names></name>
<name><surname>Norman</surname><given-names>GR</given-names></name>
</person-group>. <source>Health Measurement Scales: A Practical Guide to Their Development and Use</source>. <edition>4th ed.</edition> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2008</year>.</citation>
</ref>
<ref id="bibr79-1545968312461719">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lydick</surname><given-names>E</given-names></name>
<name><surname>Epstein</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Interpretation of quality of life changes</article-title>. <source>Qual Life Res</source>. <year>1993</year>;<volume>2</volume>:<fpage>221</fpage>-<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr80-1545968312461719">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biernaskie</surname><given-names>J</given-names></name>
<name><surname>Chernenko</surname><given-names>G</given-names></name>
<name><surname>Corbett</surname><given-names>D</given-names></name>
</person-group>. <article-title>Efficacy of rehabilitative experience declines with time after focal ischemic brain injury</article-title>. <source>J Neurosci</source>. <year>2004</year>;<volume>24</volume>:<fpage>1245</fpage>-<lpage>1254</lpage>.</citation>
</ref>
<ref id="bibr81-1545968312461719">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobkin</surname><given-names>BH</given-names></name>
<name><surname>Dorsch</surname><given-names>A</given-names></name>
</person-group>. <article-title>The promise of mHealth: daily activity monitoring and outcome assessments by wearable sensors</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2011</year>;<volume>25</volume>:<fpage>788</fpage>-<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr82-1545968312461719">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mokkink</surname><given-names>L</given-names></name>
<name><surname>Terwee</surname><given-names>C</given-names></name>
<name><surname>Knol</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content</article-title>. <source>BMC Med Res Methodol</source>. <year>2010</year>;<volume>10</volume>:<fpage>22</fpage>.</citation>
</ref>
<ref id="bibr83-1545968312461719">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Revicki</surname><given-names>D</given-names></name>
<name><surname>Hays</surname><given-names>RD</given-names></name>
<name><surname>Cella</surname><given-names>D</given-names></name>
<name><surname>Sloan</surname><given-names>J</given-names></name>
</person-group>. <article-title>Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes</article-title>. <source>J Clin Epidemiol</source>. <year>2008</year>;<volume>61</volume>:<fpage>102</fpage>-<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr84-1545968312461719">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guyatt</surname><given-names>GH</given-names></name>
<name><surname>Norman</surname><given-names>GR</given-names></name>
<name><surname>Juniper</surname><given-names>EF</given-names></name>
<name><surname>Griffith</surname><given-names>LE</given-names></name>
</person-group>. <article-title>A critical look at transition ratings</article-title>. <source>J Clin Epidemiol</source>. <year>2002</year>;<volume>55</volume>:<fpage>900</fpage>-<lpage>908</lpage>.</citation>
</ref>
<ref id="bibr85-1545968312461719">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salter</surname><given-names>K</given-names></name>
<name><surname>Jutai</surname><given-names>J</given-names></name>
<name><surname>Teasell</surname><given-names>R</given-names></name>
<name><surname>Foley</surname><given-names>N</given-names></name>
<name><surname>Bitensky</surname><given-names>J</given-names></name>
<name><surname>Bayley</surname><given-names>M</given-names></name>
</person-group>. <article-title>Issues for selection of outcome measures in stroke rehabilitation: ICF activity</article-title>. <source>Disabil Rehabil</source>. <year>2005</year>;<volume>27</volume>:<fpage>315</fpage>-<lpage>340</lpage>.</citation>
</ref>
<ref id="bibr86-1545968312461719">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terwee</surname><given-names>CB</given-names></name>
<name><surname>Bot</surname><given-names>SDM</given-names></name>
<name><surname>De Boer</surname><given-names>MR</given-names></name><etal/>
</person-group>. <article-title>Quality criteria were proposed for measurement properties of health status questionnaires</article-title>. <source>J Clin Epidemiol</source>. <year>2007</year>;<volume>60</volume>:<fpage>34</fpage>-<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr87-1545968312461719">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wyrwich</surname><given-names>KW</given-names></name>
<name><surname>Tierney</surname><given-names>WM</given-names></name>
<name><surname>Wolinksy</surname><given-names>FD</given-names></name>
</person-group>. <article-title>Further evidence supporting standard error of measurement based criterion for identifying meaningful intra-individual change in health-related quality of life</article-title>. <source>J Clin Epidemiol</source>. <year>1999</year>;<volume>52</volume>:<fpage>861</fpage>-<lpage>873</lpage>.</citation>
</ref>
<ref id="bibr88-1545968312461719">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turner</surname><given-names>D</given-names></name>
<name><surname>Schunemann</surname><given-names>HJ</given-names></name>
<name><surname>Griffith</surname><given-names>LE</given-names></name><etal/>
</person-group>. <article-title>The minimal detectable change cannot reliably replace the minimal important difference</article-title>. <source>J Clin Epidemiol</source>. <year>2010</year>;<volume>63</volume>:<fpage>28</fpage>-<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr89-1545968312461719">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stucki</surname><given-names>G</given-names></name>
<name><surname>Daltroy</surname><given-names>L</given-names></name>
<name><surname>Katz</surname><given-names>JN</given-names></name>
<name><surname>Johannesson</surname><given-names>M</given-names></name>
<name><surname>Liang</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts</article-title>. <source>J Clin Epidemiol</source>. <year>1996</year>;<volume>49</volume>:<fpage>711</fpage>-<lpage>717</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>